Cellular context-dependent "colors" of transforming growth factor-β signaling

被引:72
作者
Ikushima, Hiroaki [1 ]
Miyazono, Kohei [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo, Japan
基金
日本学术振兴会;
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; HORMONE-RELATED PROTEIN; TGF-BETA; MAMMARY-CARCINOMA; STEM-CELLS; DISEASE PROGRESSION; CANCER PROGRESSION; GASTRIC-CARCINOMA; TUMOR SUPPRESSION; KINASE INHIBITOR;
D O I
10.1111/j.1349-7006.2009.01441.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transforming growth factor (TGF)-beta signaling has interesting characteristics in the context of cancer. Although perturbations of TGF-beta signaling are strongly implicated in cancer progression, TGF-beta signaling has both tumor-suppressive and tumor-promoting effects. For example, TGF-beta inhibits cancer cell proliferation in some cellular contexts, but promotes it in others. Although several approaches to treating cancer have been considered using TGF-beta-based therapeutic strategies, the contradictory behaviors of TGF-beta have made these approaches complex. To put them to practical use, either the tumor-suppressive or tumor-promoting arm needs to be specifically manipulated. However, there is virtually no method to specifically regulate a certain cell response induced by TGF-beta. In this review, we first consider the basic machinery of TGF-beta signaling, and describe several cell responses induced by TGF-beta stimulation in specific contexts. Mechanisms by which TGF-beta can induce several responses in a cellular context-dependent fashion are discussed with established paradigms and models. We also address perspectives on the specific control of only a subset of numerous cell responses induced by TGF-beta stimulation. Such methods will aid specific regulation of either the tumor-suppressive or tumor-promoting arm of the TGF-beta pathway and in realization of TGF-beta-based treatment of malignant tumors. (Cancer Sci 2010; 101: 306-312).
引用
收藏
页码:306 / 312
页数:7
相关论文
共 71 条
[11]   Transforming growth factor-β promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1 [J].
Ehata, Shogo ;
Hanyu, Aki ;
Hayashi, Makoto ;
Aburatani, Hiroyuki ;
Kato, Yukio ;
Fujime, Makoto ;
Saitoh, Masao ;
Miyazawa, Keiji ;
Imamura, Takeshi ;
Miyazono, Kohei .
CANCER RESEARCH, 2007, 67 (20) :9694-9703
[12]   Ki26894, a novel transforming growth factor-β type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line [J].
Ehata, Shogo ;
Hanyu, Aki ;
Fujime, Makoto ;
Katsuno, Yoko ;
Fukunaga, Erina ;
Goto, Kouichiro ;
Ishikawa, Yuichi ;
Nomura, Kimie ;
Yokoo, Hiroshi ;
Shimizu, Toshiyuki ;
Ogata, Etsuro ;
Miyazono, Kohei ;
Shimizu, Kiyoshi ;
Imamura, Takeshi .
CANCER SCIENCE, 2007, 98 (01) :127-133
[13]   Cancer epigenomics: DNA methylomes and histone-modification maps [J].
Esteller, Manel .
NATURE REVIEWS GENETICS, 2007, 8 (04) :286-298
[14]   Specificity and versatility in TGF-β signaling through Smads [J].
Feng, XH ;
Derynck, R .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2005, 21 :659-693
[15]   Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? [J].
Filipowicz, Witold ;
Bhattacharyya, Suvendra N. ;
Sonenberg, Nahum .
NATURE REVIEWS GENETICS, 2008, 9 (02) :102-114
[16]  
FRIEDMAN E, 1995, CANCER EPIDEM BIOMAR, V4, P549
[17]   RNA interference targeting transforming growth factor-β enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo [J].
Friese, MA ;
Wischhusen, J ;
Wick, W ;
Weiler, M ;
Eisele, G ;
Steinle, A ;
Weller, M .
CANCER RESEARCH, 2004, 64 (20) :7596-7603
[18]   The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 [J].
Gregory, Philip A. ;
Bert, Andrew G. ;
Paterson, Emily L. ;
Barry, Simon C. ;
Tsykin, Anna ;
Farshid, Gelareh ;
Vadas, Mathew A. ;
Khew-Goodall, Yeesim ;
Goodall, Gregory J. .
NATURE CELL BIOLOGY, 2008, 10 (05) :593-601
[19]   Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis [J].
Guise, TA ;
Yin, JJ ;
Taylor, SD ;
Kumagai, Y ;
Dallas, M ;
Boyce, BF ;
Yoneda, T ;
Mundy, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (07) :1544-1549
[20]  
HAHN SA, 1995, CANCER RES, V55, P4670